Mark Long

39PUBLICATIONS
205CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Molecular targetsWomen's studies (incl. girls' studies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 01, 2026
Nuclear-specific reductive carboxylation of alpha-ketoglutarate fuels histone acetylation to induce chromatin accessibility and gene activation.

|Nov 19, 2025
HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma.

Kennedy S Humphrey, Katherine J Crawford, Bharani Muppavarapu

|Nov 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.

Justine J Jacobi, Kristine M Wadosky, Neha Jaiswal

|Oct 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi

|Aug 26, 2025
Mutational landscape of triple-negative breast cancer in African American women.

Song Yao, Lei Wei, Qiang Hu

|Aug 06, 2025
MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression.

Hiroki Ozawa, Yin Wang, Henry G Withers

Pageof 7

Frequent Collaborators

14 joint publications

Donald Kufe

8 joint publications

Qiang Hu

6 joint publications

Henry Withers

5 joint publications

Tao Liu